Silver-stained organizer regions and immunoglobulins in cutaneous keratoacanthomas and squamous cell carcinomas

Pathology Research and Practice

Volumn 203, Issue 9, 2007, Pages 659-665

  Aroni, Kiriaki ^a   Mastoraki, Aikaterini ^a   Kyriazi, Evridiki ^a   Ioannidis, Eleftherios ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Immunohistochemistry; Keratoacanthomas; Squamous cell carcinomas

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS;

ARTICLE; CANCER GRADING; CANCER STAGING; CELL ACTIVITY; CELL COUNT; CELL INFILTRATION; CHROMOSOME NOR; CONTROLLED STUDY; DISEASE SEVERITY; EPIDERMIS CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; KERATOACANTHOMA; MAJOR CLINICAL STUDY; PSEUDOTUMOR; SILVER STAINING; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 34548124940     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.05.015     Document Type: Article

References (39)

1. Albrecht S., Jambrosic J.A., and Kahn H.J. Nucleolar organizer regions in superficial spreading melanoma with nodule. Mod. Pathol. 2 6 (1989) 666-670
2. Barzilai A., Goldberg I., Yulash M., Pavlotsky F., Zuckerman A., Trau H., Azizi E., and Kopolovic J. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma. Am. J. Dermatopathol. 20 5 (1998) 473-477
3. Bustamante R., Schmitt D., Pillet G.C., and Thivolet J. Immunoglobulin-producing cells in the inflammatory infiltrates of cutaneous tumors. Immunocytologic identification in situ. J. Invest. Dermatol. 68 (1977) 346-349
4. Callen J.P. Possible precursors to epidermal malignancies. In: Friedman R., et al. (Ed). Cancer of the Skin (1991), W.B. Saunders Co., Philadelphia 3-27
5. Crocker J., Boldy D.A.R., and Egan M.J. How we count (AgNORs)? Proposals for a standardized approach. J. Pathol. 158 (1989) 185-188
6. Della Sanda L., Preziosi R., Mazzoni M., and Marcato P.S. Cell proliferation patterns in canine infundibular keratinizing acanthoma and well differentiated squamous cell skin carcinoma. Eur. J. Histochem. 46 2 (2002) 165-172
7. Egan M.J., and Crocker J. Nucleolar organizer regions in cutaneous tumors. J. Pathol. 154 (1988) 247-253
8. Euvrard S., Chardonnet Y., Hermier C., Viac J., and Thivolet J. Warts and epidermoid carcinoma after renal transplantation. Ann. Dermatol. Venereol. 116 (1989) 201-211
9. Evans A.T., Blessing K., Orrell J.M., and Grant A. Mitotic indices, anti-PCNA immunostaining, and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour. J. Pathol. 168 1 (1992) 15-22
10. Flannery G.R., and Muller H.K. Immune response to human keratoacanthoma. Br. J. Dermatol. 101 (1979) 625-630
11. Gambini C., Casazza S., Borgiani L., Canepa M., Rovida S., Rongioletti E., and Rebora A. Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma. Arch. Dermatol. 128 4 (1992) 537-542
12. Gassenmaier A., Pfister H., and Hornstein O.P. Human papillomavirus 25-related DNA in solitary keratoacanthoma. Arch. Dermatol. Res. 279 (1986) 73-76
13. Gayraud A., Lorenzato M., Sartelet H., Grosshans E., Hopfner C., Mehaut S., Bernard P., and Durlach A. Malignant blue nevus: clinicopathologic study with AgNOR measurement. Seven cases. Ann. Dermatol. Venereol. 129 12 (2002) 1359-1364
14. Gonzalez A.P., Kumar D., and Sanchez R.L. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting. Am. J. Dermatopathol. 16 4 (1994) 372-376
15. Gupta A.K., Cherman A.M., and Tyring S.K. Viral and nonviral uses of imiquimod: a review. J. Cutan. Med. Surg. 8 5 (2004) 338-352
16. Hackel H., Burg G., Lechner W., Stolz W., Ring J., and Braun-Falco O. Keratoacanthoma centrifugum marginatum. Hautarzt 40 12 (1989) 763-766
17. Heinisch G., and Barth J. Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology. Zentralbl. Pathol. 140 1 (1994) 95-101
18. Heinisch G., and Barth J. AgNOR expression in skin tumors. Studies of melanocytic, epidermal and fibrohistiocytic lesions. Hautarzt 46 3 (1995) 177-185
19. Heinisch G., and Wozel G. Determination of epidermal proliferative activity in experimental mouse tail test by AgNOR analysis. Exp. Toxicol. Pathol. 47 1 (1995) 19-23
20. Hofstadter F., Knuckel R., and Ruschoff J. Cell proliferation assessment in oncology. Virchows Arch. 427 3 (1995) 323-341
21. Howat A.J., Wright A.L., Cotton D.W., and Reeve S. AgNORs in benign dysplastic and malignant melanocytic lesions. Am. J. Dermatopathol. 12 2 (1990) 156-161
22. Kanitakis J., Hoyo E., Hermier C., Chouvet B., and Thivolet J. Nucleolar organizer region enumeration in keratoacanthoma squamous cell carcinomas of the skin. Cancer 69 12 (1992) 2937-2941
23. Kittas C., Aroni K., Kotsis L., and Papadimitriou C.S. Distribution of lysozyme, a1-antichymotrypsin and a1-antitrypsin in adenocarcinomas of the stomach and large intestine. Virchows Arch. A 398 (1982) 139-147
24. Kossard S., and Wilkinson B. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma. J. Cutan. Pathol. 22 2 (1995) 132-136
25. Lever W.F., and Schaumburg-Lever G. Tumors and cysts of the epidermis. Histopathology of the Skin vol. 26 (1991), J.B. Lipp Co., Philadelphia 560-563
26. Li L.X., Crotty K.A., Palmer A.A., Kril J.J., Scolyer R.A., and Thompson J.F. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions. Am. J. Dermatopathol. 25 3 (2003) 190-197
27. Pich A., Chiusa L., Margaria E., and Aloi F. Proliferative activity in the malignant cellular blue nevus. Hum. Pathol. 24 12 (1993) 1323-1329
28. Poleksic S., and Yeung K.Y. Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutogenic effect of polychemotherapy in a patient with Hodgkin's disease?. Cancer 41 (1978) 12-16
29. Qiu B.S., Xu L.Z., Kong J.C., Chen H.L., and Tao L.D. AgNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas. Clin. Med. J 105 1 (1992) 30-33
30. Rebolledo Godoy A.P., Rebolledo Godoy M., Meissner C., and Oehmichen M. Proliferative activity of epidermal basal cells after wounding. AgNOR counts compared with bromodeoxyuridine reactivity in rats. Exp. Toxicol. Pathol. 53 1 (2001) 65-69
31. Rebora A. Prognosing melanomas: the argyrophilic nucleolar organizer region approach. Dermatology 185 3 (1992) 166-168
32. Reis J.P., Tellechea O., and Baptista A.P. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions. Dermatologica 183 2 (1991) 136-138
33. Roman S.G., Farolan M.J., McDonald A., Manaligod J.R., and Das Gupta T.K. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma. J. Cutan. Pathol. 21 6 (1994) 494-499
34. Rothe M.J., Nowak M., and Kerdel F.A. The mast cell in the health and disease. Am. Acad. Dermatol. 23 (1990) 615-624
35. Schnur L., and Bozzo P. Metastasizing keratoacanthoma. The difficulties in differentiating keratoacanthomas from squamous cell carcinomas,. Plast. Reconstr. Surg. 62 (1978) 258-262
36. Schon M.P., and Schon M. The small-molecule immune response modifier imiquimod - its mode of action and clinical use in the treatment of skin cancer. Expert Opin. Ther. Targets 10 1 (2006) 69-76
37. B.F. Straka, J.M. Grant-Kels, Keratoacanthoma, 1991. In: R.J. Friedman, et al. (Eds), Cancer of the Skin, vol. 27. J.B. Lipp Co., Philadelphia, pp. 390-407.
38. Toonstra J., and van Wichen F. Immunohistochemical characterization of plasma cells in Zoon's balanoposthitis and (pre)malignant skin lesions. Dermatologica 172 (1986) 77-81
39. Viac J., Bustamante R., and Thivolet J. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumor. Br. J. Dermatol. 97 (1977) 1-10